Skip to content

300760.SZ

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

SZSE · Healthcare · C 制造业 · CN

CNY 175.36
−1.37%
Ask drillr
  • Oct 29, 2026, 11:05 UTC

    Mindray Medical reported third-quarter revenue of 9.35 billion yuan, up 2.85% year over year, and net profit attributable to shareholders of 2.387 billion yuan, down 4.55%; for the first three quarters, revenue was 27.097 billion yuan, up 4.89%, and net profit was 7.184 billion yuan, down 5.10%.

  • Oct 12, 2026, 08:17 UTC

    Mindray Medical's controlling shareholder, Magnifice HK Ltd., pledged 6.5 million company shares to CMB Wing Lung Bank Ltd. and Nanyang Commercial Bank Ltd..

  • Aug 29, 2026, 11:56 UTC

    Mindray Medical International disclosed its 2026 semi-annual report on August 28, 2026, reporting revenue of 17.747 billion yuan, up 6.00% year-on-year, and net profit attributable to shareholders of 4.797 billion yuan, down 5.37% year-on-year.

  • Aug 28, 2026, 10:26 UTC

    Mindray Medical announced a cash dividend of 13.3 yuan per 10 shares (tax included) based on its total share capital of 1.212 billion shares, with no bonus shares or capital reserve conversion.

  • Aug 10, 2026, 10:53 UTC

    Mindray Medical completed the cancellation of 641,963 treasury shares on August 7, 2026, reducing its total share capital from 1,212,441,394 shares to 1,211,799,431 shares.

  • Jul 30, 2026, 03:41 UTC

    Mindray Medical established a wholly-owned medical technology subsidiary in Zhengzhou with a registered capital of 5 million yuan.